Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Reversal of steroid insensitivity in COPD by theophylline
2006-003561-13Phase 4Completed
- Sponsor
- Imperial College London
- Start
- Jan 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of theophylline and fluticasone in chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by Imperial College London. Primary endpoint: Sputum inflammatory cell counts. Started Jan 2012; status: completed.
02
Drugs
theophyllinefluticasone
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2006-003561-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003561-13.